Sign Out
Primary Hypercholesterolaemia/Homozygous Familial Hypercholesterolaemia (HoFH): ZENON is indicated for substitution therapy in adult patients who are adequately controlled with rosuvastatin and ezetimibe given concurrently at the same dose level as in the fixed combination, but as separate products, as adjunct to diet for treatment of primary hypercholesterolaemia (heterozygous familial) or homozygous familial hypercholesterolaemia.
ROSUVASTATIN/EZETIMIBE fixed dose combination should not be used as initial therapy.
Lanjutkan dengan Google